Results 351 to 360 of about 149,141 (380)
Some of the next articles are maybe not open access.
2011
Metronidazole compound (1-β-hydroxyethyl-2-methyl-5-nitroimidazole) is a commonly used agent for the treatment of anaerobic infections. It is the only one of the five nitroimidazoles (nimoprazole, carnidazole, metronidazole, sulnidazole, and tinidazole) approved by the FDA for use in the United States (Fig. 11.1).
Robert W. Finberg, Roy Guharoy
openaire +2 more sources
Metronidazole compound (1-β-hydroxyethyl-2-methyl-5-nitroimidazole) is a commonly used agent for the treatment of anaerobic infections. It is the only one of the five nitroimidazoles (nimoprazole, carnidazole, metronidazole, sulnidazole, and tinidazole) approved by the FDA for use in the United States (Fig. 11.1).
Robert W. Finberg, Roy Guharoy
openaire +2 more sources
Metronidazole-induced encephalopathy: a systematic review
Journal of Neurology, 2018C. Sørensen +3 more
semanticscholar +1 more source
International Journal of Environmental Science and Technology, 2018
Mohammad Malakootian +2 more
semanticscholar +1 more source
Mohammad Malakootian +2 more
semanticscholar +1 more source